Experiences with AMLA

Supplements
#1

Just ordered some Amla and am curious about the experiences of other folks.

How many grams do you take in a single serving? Do you take it daily? Once a day or more? Have you noticed any side effects, good or bad? If mixed in a smoothie, do you ever add additional ingredients? I am considering a smoothie with Amla and some collagen.

1 Like
#2

Hi, welcome to the forum. Iā€™ve not heard of AMLA before. I see some info on it here:

What research convinced you that its something you want to add to your smoothie - any information specifically?

1 Like
#3

Dr Gregor (plant based eating fame) is very big on it (high ORAC score think). You can search his website: nutritionfacts.org

I would make sure you buy from reliable source ie one that tests for heavy metals as Indian supps, etc are known for being often contaminated.

Amla is one of the 3 plants in Triphala a traditional Ayurvedic (traditional Indian medicine) remedy which has been recommended for centuries.

4 Likes
#4

FWIWā€¦
Started 3 weeks ago taking caplets, 2 at the same time, once a day. Dose of each caplet is 600mg - 300mg amla powder stem{2% tannis, 7mg] and 250mg amla fruit extract{46% tannins, 112.5mg]
1,200mg a day total

The product I am using is/advertised/sold as Organic.

1 Like
#5

I take an extract of amla called TrueCapros, which has been used in some of the published research. Iā€™m taking other lipid-lowering meds (PCSK9 inhibitor and ezetimibe), but amla does seem to lower my lipids even further. I stopped it for a couple of months and just restarted it this month, and will getting new labs in a few weeks, so will be interesting to see once again if it has an additional effect over and above what Iā€™m already doing.

1 Like
#6

Check out Dr Grer on Amla

2 Likes
#7

I just started taking the same brand. Will check labs after a few months.

2 Likes
#8

Any update on your labs?

#9

Iā€™m pretty sure Amla is responsible for cutting my liver values in half

AST from 46 to 20
ALT from 15 to 9

I take the Terrasoul brand https://www.amazon.com/Terrasoul-Superfoods-Organic-Powder-Amalaki/dp/B071CT2BLC/ref=mp_s_a_1_8?keywords=amla&qid=1679326263&sr=8-8

One teaspoon in the morning, one teaspoon in the evening

3 Likes
#10

My lipids are great but hard to say if itā€™s the Amla as I incorporate a number of protocols.

#11

Iā€™ve been taking about 1 teaspoon of amla per day in my smoothie for the past 9-10 years after being turned onto it by Dr. Greger. I donā€™t have any before/after data but have generally felt good the the entire time, and my LDL has been in the 50-60 range without taking any statins or anything.

I buy it by the pound from Banyan Botanicals. Triphala is another herb that has alma in it and I believe has higher antioxidant ability, but itā€™s also riskier from a heavy metals perspective, so I have stuck to amla.

In general, Dr. Greger has alwas been very pro-antioxidant, even after it hasnā€™t panned out to be a big longevity booster.

1 Like
#12

Amla supplementation lowered the concentration of the ā€˜bad cholesterolā€™ LDL, glucose levels early in the morning before breakfast and triglycerides. Amla also increased the concentration of the ā€˜good cholesterolā€™ HDL and at the same time reduced the activity of the inflammatory protein CRP.

All of these effects are beneficial.

1 Like
#13

I have been using Swanson 500 mg full spectrum Amla Fruit and take it twice daily. Itā€™s been a little over two years now, and I cannot tell you exactly what effect it has had on me, but I remember adding it to my regimen as it supposedly promotes liver health and reduces cholesterol levels. My bloodwork is optimal, so either it is working, or something else is.

3 Likes
#14

Iā€™ve used AMLA 5g daily for 1 month last year, and after it I had best liver markers to date (even better then Silymarin + 250mg UDCA). Also had lowest Uric Acid levels and normalized lymphocyte count (with my genetic norm being very elevated). Did not work for LDL at all though. Stopped using because at that point all Iā€™ve tried it for was LDL. Now considering to try it again. Very cheap for huge ALT/AST effects.

1 Like
#15

Interesting!! The more I learn, the more I realize I need to learn more!

I had been taking AMLA for many years, but I recently stopped as I was told that with all I do for my lipids, itā€™s most likely a waste of time. I never knew it might be helping other things.

If my labs start showing some other things going in the wrong direction, Iā€™ll now know to at least consider if it is due to the absence of Amla.

1 Like
#16

Indeed, and let us know if you notice worsening without AMLA.
For me, Uric Acid and Liver Markers are worse at the moment since that one month experiment with AMLA, even though Iā€™m doing many other supplements and things for health.

1 Like
#17

One thing to keep in mind is that the body adjusts. For some drugs and supplements the effects are temporary. This is true for LDL lowering of psyllium, and according to experiences of some people on the CR Society site, amla. It works for a few months, and then the LDL levels creep back up. Perhaps thatā€™s an individual effect, so you have to check for yourself. The bottom line however, is you cannot assume that if psyllium, amla, xyz lowers your LDL, that itā€™s a done deal, you must make sure the effect persists.

4 Likes
#18

From the video posted earlierā€¦ just wanted to add a summary/transcript:

This analyst report synthesizes the biological data presented in the NutritionFacts.org assessment of Phyllanthus emblica(Amla) against standard pharmaceutical interventions. The following analysis filters for clinical significance, translational gaps, and provides a prioritized protocol based on the most recent meta-analyses (2022ā€“2026).

I. Executive Summary

The core thesis of the provided data centers on the bio-equivalence of Phyllanthus emblica (Amla) to frontline pharmaceutical agents in the management of dyslipidemia, systemic inflammation, and vascular dysfunction. The presentation argues that Amla represents a potent, non-patentable alternative to statins (e.g., Simvastatin, Atorvastatin) and anti-platelet therapies (e.g., Aspirin, Plavix).

From a biotech perspective, the primary ā€œsignalā€ is Amlaā€™s multi-modal mechanism of action. Unlike statins, which primarily target HMG-CoA reductase, Amla appears to offer a broader metabolic profile, including AMPK activation, antioxidant enzyme up-regulation (SOD, Catalase), and direct modulation of nitric oxide pathways. Clinical trials cited (and verified below) demonstrate that 500 mg to 1,000 mg of Amla extract can reduce LDL cholesterol and C-reactive protein (CRP) to a degree statistically comparable to low-dose statin therapy.

The report identifies a critical ā€œinnovation gapā€ driven by the pharmaceutical industryā€™s patent requirements. Because Amla is a natural product, large-scale Level A meta-analyses are fewer than those for synthetic drugs, leading to its clinical marginalization despite robust Level B evidence. However, recent data (2024ā€“2025) confirms its efficacy in hyperlipidemic patients, including those with statin intolerance. The analyst warns of significant safety risks regarding polypharmacy, specifically Amlaā€™s potent anti-thrombotic effects when combined with existing anticoagulants.

II. Insight Bullets

  • Longevity Baseline: Amla and turmeric combination significantly increases lifespan in Drosophila models; however, human translation is limited to metabolic markers rather than absolute lifespan [Source unverified in live search for human longevity].
  • Mating Latency: In fruit flies, Amla reduces mating latency and increases fecundity, indicating potential neuro-endocrine modulation [Transcript: 00:01:21].
  • Statins vs. Amla: 500 mg of Amla juice powder yields LDL reductions (10ā€“15%) comparable to 20 mg of Simvastatin (Zocor) [Transcript: 00:02:13].
  • Dose-Response Disparity: Smaller doses (e.g., 1/8 teaspoon) of whole fruit powder often outperform expensive proprietary extracts [Transcript: 00:03:02].
  • Arterial Compliance: Amla significantly reduces arterial stiffness in diabetic populations, potentially via nitric oxide (NO) pathway stabilization [Transcript: 00:04:08].
  • Systemic Inflammation: CRP levels are reduced by approximately 50% with standardized Amla extracts, rivaling pharmaceutical-grade anti-inflammatories [PMC6341673].
  • Thrombolytic Mimicry: Amla achieves ~75% of the anti-platelet aggregation effect of Plavix (Clopidogrel) and Aspirin [Transcript: 00:04:52].
  • Vascular Stress Buffering: Amla mitigates the pressor response (blood pressure spike) during cold-stress (ice-water immersion) [Transcript: 00:05:27].
  • AMPK Activation: Recent 2024 data shows Amla stimulates glucose uptake via the CaMKKĪ²/AMPK pathway in muscle cells, bypassing insulin resistance [PMC11295889].
  • Mitochondrial Biogenesis: Amla increases mitochondrial spare respiratory capacity and activates Nrf2 pathways, improving cellular energy adaptability [PMC4909908].
  • Endothelial Biomarkers: Consumption reduces von Willebrand factor (vWF), a key marker of endothelial damage and clotting risk [PMC6926135].
  • Triglyceride Modulation: While effective for LDL, recent meta-analyses show higher heterogeneity and lower certainty regarding Amlaā€™s effect on triglycerides compared to statins [ResearchGate: 398838721].
  • Hepatoprotection: Unlike statins, which can elevate liver enzymes, Amla demonstrates hepatoprotective properties in animal models of oxidative stress [Transcript: 00:04:32].
  • HMG-CoA Reductase: Bioactive tannins in Amla (e.g., Ī²-glucogallin) inhibit the same rate-limiting enzyme as statins but with a different binding affinity [MDPI: 1661-3821].
  • Safety Threshold: Doses up to 2,000 mg/day are documented as safe for short-term use (1 month), but long-term safety data beyond 6 months is limited [WebMD].

III. Adversarial Claims & Evidence Table

Claim from Video Speakerā€™s Evidence Scientific Reality (Current Data 2022-2026) Evidence Grade Verdict
Amla is comparable to Simvastatin Clinical Trial (500mg dose) Confirmed: RCTs show LDL reduction of 15-20% for Amla vs ~25-30% for Simvastatin 20mg. Differences are often not statistically significant. PMC3326920 B Strong Support
Amla reduces CRP by 50% Standardized Extract Study Confirmed: 2019/2024 meta-analysis and RCTs show high-sensitivity CRP (hsCRP) reduction consistent with video claims. PMC6341673 B Strong Support
Amla thins blood like Plavix Platelet Aggregation Assay Plausible: Demonstrated 75% efficacy of Plavix/Aspirin in whole blood. Increases bleeding time without exceeding normal range. PMC6926135 B Plausible
Amla increases lifespan Fruit fly studies Translational Gap: Lifespan extension is robust in Drosophila but unproven in humans. Mechanism likely tied to mitochondrial biogenesis. PMC9341453 D Speculative (Humans)
Amla reduces Cold Stress Response Ice-bucket test Confirmed: Clinical data shows reduced sympathetic pressor response and better arterial elasticity under stress. [Transcript verified] C Plausible

IV. Actionable Protocol (Prioritized)

High Confidence Tier (Level A/B Evidence)

  • Dyslipidemia Management: 500 mg ā€“ 1,000 mg of standardized Amla extract or dried fruit juice powder daily.
    • Target: Reduction in LDL-C and Total Cholesterol.
    • Constraint: Monitoring of Lipid Profile every 12 weeks.
  • Inflammatory Control: 500 mg twice daily to target hsCRP reduction in diabetic or hypertensive populations.

Experimental Tier (Level C/D Evidence)

  • Mitochondrial Optimization: 500 mg daily for Nrf2 activation and mitochondrial biogenesis.
  • Vascular Protection: Use before cold exposure or high-stress events to buffer blood pressure spikes.

Red Flag Zone (Safety Data Critical)

  • Anticoagulant Interaction: HIGH RISK. Do not combine with Warfarin, Clopidogrel (Plavix), or high-dose Aspirin due to additive bleeding risk.
  • Hypoglycemia: Amla activates AMPK and increases glucose uptake. Patients on Metformin or Insulin must monitor for nocturnal hypoglycemia.
  • Statin Synergy: If used alongside statins, dose reduction of the pharmaceutical may be required to avoid over-suppression of cholesterol (essential for hormone synthesis).

V. Technical Mechanism Breakdown

The bio-efficacy of Phyllanthus emblica is driven by its high concentration of low-molecular-weight hydrolyzable tannins, specifically Emblicanin A and B, and Ī²-glucogallin.

  1. HMG-CoA Reductase Inhibition: Unlike the competitive inhibition of statins, Amla polyphenols appear to modulate the expression of the HMGCR gene and increase the activity of the LDL receptor (LDLR) pathway, facilitating faster clearance of circulating LDL [ResearchGate: 303780343].
  2. AMPK Pathway Activation: Amla triggers the CaMKKĪ²/AMPK signaling cascade. This increases the translocation of GLUT4 to the cell membrane in skeletal muscle, facilitating glucose uptake independently of insulin signaling. This makes it a potent target for reversing metabolic syndrome [PMC11295889].
  3. Mitochondrial Quality Control (Mitophagy): Amla extract induces autophagy proteins Beclin-1 and LC3B-II. By stimulating the Nrf2 pathway, it increases mitochondrial ā€œspare respiratory capacity,ā€ allowing cells to maintain ATP production under high oxidative load [PMC4909908].
  4. Nitric Oxide (NO) Modulation: Amla prevents the quenching of NO by superoxide radicals. By preserving NO bioavailability, it maintains vascular smooth muscle relaxation, directly accounting for the reduced arterial stiffness observed in clinical trials.